Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by touchpodcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by touchpodcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Updates in BCMA-directed therapies in multiple myeloma from ASH 2024

55:57
 
Share
 

Manage episode 464804308 series 3389426
Content provided by touchpodcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by touchpodcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

touchCONGRESS for ONCOLOGY

Multiple myeloma expert Prof. Katja Weisel summarizes key data for BCMA-targeted agents in multiple myeloma presented at the 2024 American Society of Hematology (ASH) Annual Meeting and Exposition. Prof. Weisel is then joined by fellow experts Dr Nisha Joseph and Prof. Roman Hájek to discuss the potential implications of the data for clinical practice.

The experts

  • Prof. Katja Weisel, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
  • Dr Nisha Joseph, Emory University School of Medicine, Atlanta, GA, USA
  • Prof. Roman Hájek, University Hospital Ostrava, Ostrava, Czech Republic

This touchPODCAST is for HCPs outside of the USA and UK.

This activity is funded by an independent medical education grant from GSK.

This activity is provided by touchIME. touchIME is an EBAC® accredited provider.

For further information visit our website:

https://touchoncologyime.org/bcma-directed-therapies-in-multiple-myeloma-ash2024/

  continue reading

102 episodes

Artwork
iconShare
 
Manage episode 464804308 series 3389426
Content provided by touchpodcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by touchpodcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

touchCONGRESS for ONCOLOGY

Multiple myeloma expert Prof. Katja Weisel summarizes key data for BCMA-targeted agents in multiple myeloma presented at the 2024 American Society of Hematology (ASH) Annual Meeting and Exposition. Prof. Weisel is then joined by fellow experts Dr Nisha Joseph and Prof. Roman Hájek to discuss the potential implications of the data for clinical practice.

The experts

  • Prof. Katja Weisel, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
  • Dr Nisha Joseph, Emory University School of Medicine, Atlanta, GA, USA
  • Prof. Roman Hájek, University Hospital Ostrava, Ostrava, Czech Republic

This touchPODCAST is for HCPs outside of the USA and UK.

This activity is funded by an independent medical education grant from GSK.

This activity is provided by touchIME. touchIME is an EBAC® accredited provider.

For further information visit our website:

https://touchoncologyime.org/bcma-directed-therapies-in-multiple-myeloma-ash2024/

  continue reading

102 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play